186 related articles for article (PubMed ID: 37971525)
1. [New treatment options in systemic therapy for breast cancer and associated new side effects].
Landin J; Weber WP; Vetter M
Ther Umsch; 2023 Oct; 80(8):353-358. PubMed ID: 37971525
[TBL] [Abstract][Full Text] [Related]
2. Advances in chemical pharmacotherapy to manage advanced breast cancer.
Gombos A; Awada A
Expert Opin Pharmacother; 2017 Jan; 18(1):95-103. PubMed ID: 27927046
[TBL] [Abstract][Full Text] [Related]
3. Metastatic breast cancer: understanding current management options.
McGinn K; Moore J
Oncol Nurs Forum; 2001 Apr; 28(3):507-12; quiz 513-4. PubMed ID: 11338758
[TBL] [Abstract][Full Text] [Related]
4. Optimal management of brain metastases from breast cancer. Issues and considerations.
Bartsch R; Berghoff AS; Preusser M
CNS Drugs; 2013 Feb; 27(2):121-34. PubMed ID: 23239265
[TBL] [Abstract][Full Text] [Related]
5. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
6. Clinical Implications of the Progression-Free Survival Endpoint for Treatment of Hormone Receptor-Positive Advanced Breast Cancer.
Kaklamani VG
Oncologist; 2016 Aug; 21(8):922-30. PubMed ID: 27256875
[TBL] [Abstract][Full Text] [Related]
7. [Adjuvant therapies in breast carcinoma].
Joss R; Brunner K
Schweiz Rundsch Med Prax; 1991 Mar; 80(11):247-54. PubMed ID: 2024099
[TBL] [Abstract][Full Text] [Related]
8. [Taxanes in primary systemic treatment of breast cancer].
von Minckwitz G
Onkologie; 2003 Dec; 26 Suppl 7():21-5. PubMed ID: 14716138
[TBL] [Abstract][Full Text] [Related]
9. [Adjuvant chemotherapy of early stage breast cancer].
Boér K
Orv Hetil; 2010 Feb; 151(9):344-53. PubMed ID: 20159750
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
[TBL] [Abstract][Full Text] [Related]
11. Brain metastases as site of first and isolated recurrence of breast cancer: the role of systemic therapy after local treatment.
Niwińska A
Clin Exp Metastasis; 2016 Oct; 33(7):677-85. PubMed ID: 27225754
[TBL] [Abstract][Full Text] [Related]
12. Trastuzumab-deruxtecan: an investigational agent for the treatment of HER2-positive breast cancer.
Bartsch R
Expert Opin Investig Drugs; 2020 Sep; 29(9):901-910. PubMed ID: 32701032
[TBL] [Abstract][Full Text] [Related]
13. The St. Gallen Prize Lecture 2011: evolution of long-term adjuvant anti-hormone therapy: consequences and opportunities.
Jordan VC; Obiorah I; Fan P; Kim HR; Ariazi E; Cunliffe H; Brauch H
Breast; 2011 Oct; 20 Suppl 3(Suppl 3):S1-11. PubMed ID: 22015273
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer.
Barrett SV
J R Coll Physicians Edinb; 2010 Dec; 40(4):335-8; quiz 339. PubMed ID: 21132144
[TBL] [Abstract][Full Text] [Related]
15. Optimal systemic therapy for premenopausal women with hormone receptor-positive breast cancer.
Jankowitz RC; McGuire KP; Davidson NE
Breast; 2013 Aug; 22 Suppl 2():S165-70. PubMed ID: 24074781
[TBL] [Abstract][Full Text] [Related]
16. Medical management of early-stage breast cancer.
Bookman MA; Goldstein LJ; Scher RM
Curr Probl Cancer; 1991; 15(4):157-232. PubMed ID: 1874006
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant systemic therapy for breast cancer: the Westmead experience.
Cocco AM; Messer D; Brown A; Sriram N; Gilchrist J; Al-Mansouri L; Kefford R; Meybodi F; French J; Hsu J; Elder E
ANZ J Surg; 2018 Jun; 88(6):640-644. PubMed ID: 28922685
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant therapy for breast cancer.
Hortobagyi G
Annu Rev Med; 2000; 51():377-92. PubMed ID: 10774471
[TBL] [Abstract][Full Text] [Related]
19. [Platinum-based chemotherapy in triple negative breast cancer].
Eckstein N; Haas B
Dtsch Med Wochenschr; 2012 Feb; 137(7):333-6. PubMed ID: 22318849
[TBL] [Abstract][Full Text] [Related]
20. Pharmacotherapeutics of capecitabine and trastuzumab in the treatment of metastatic breast cancer.
McCauley S; Carter G; Bennett M; McNally O; Rogers KM
Br J Nurs; 2020 Feb; 29(3):S4-S9. PubMed ID: 32053446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]